LIMINATUS PHARM Price to Free Cash Flow Ratio 1971-1970 | LIMN

Historical price to free cash flow ratio values for LIMINATUS PHARM (LIMN) since 1971. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
LIMINATUS PHARM Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-05-08 6.15 0.00
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.000B $0.000B
Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.886B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Aduro Clean Technologies (ADUR) Canada $0.157B 0.00
Range Capital Acquisition (RANG) United States $0.144B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.099B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.092B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Youxin Technology (YAAS) China $0.040B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.035B 0.00
Sky Quarry (SKYQ) United States $0.015B 0.00
PicoCELA (PCLA) Japan $0.011B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.010B 0.00
SMART DGTL GRP (SDM) $0.000B 0.00
WINCHESTER BCP (WSBK) $0.000B 0.00
YUANBAO INC (YB) China $0.000B 0.00
CANTOR EQ PT II (CEPT) $0.000B 0.00